(Q51680964)

English

Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.

scientific article published in July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. (English)

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

object named as

Hong Ding

2

0 references

author name string

Na Li

1

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Peili Fan

3

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Xiyuan Lin

4

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Chen Xu

5

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Wenping Wang

6

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Zhizhang Xu

7

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Jiyao Wang

8

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

publication date

1 July 2010

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Ultrasound in Medicine and Biology

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

36

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

7

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

1066-1075

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Parameters of cerebral perfusion in phase-inversion harmonic imaging (PIHI) ultrasound examinations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Non-invasive evaluation of liver cirrhosis using ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Semiquantitative analysis of ultrasonic cerebral perfusion imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic vein transit time of SonoVue: a comparative study with Levovist.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Chronic hepatitis B: update of recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Validation of ultrasound contrast destruction imaging for flow quantification

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Quantification of hepatic parenchymal blood flow by contrast ultrasonography with flash-replenishment imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Hepatic transit time of ultrasound contrast in biopsy characterized liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Fibrosis and cirrhosis reversibility: clinical features and implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Contrast agent specific imaging modes for the ultrasonic assessment of parenchymal cerebral echo contrast enhancement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

The role of liver biopsy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

The nomenclature of chronic hepatitis: time for a change.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Direct and indirect evidence for the reversibility of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.04.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.ULTRASMEDBIO.2010.04.012

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20620694

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51680964&oldid=2152073590"